Form 4 Tracker
INCYTE CORP
INCY

22 insider filings · Latest: May 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 2, 2025Sep 2 8:07 PMSHEILA DENTON
Proposed Sale
598$84.97$50.8K

View →

Aug 15, 2025Aug 15 8:05 PMSHEILA DENTON
Proposed Sale
277$86.81$24.0K

View →

Aug 13, 2025Aug 13 8:18 PMBARRY FLANNELLY
Proposed Sale
75,963$82.51$6.3M

View →

Aug 12, 2025Aug 12 8:21 PMBARRY FLANNELLY
Proposed Sale
14,037$80.00$1.1M

View →

Aug 4, 2025Aug 4 8:05 PMSHEILA DENTON
Proposed Sale
598$75.77$45.3K

View →

Jul 21, 2025Jul 21 8:01 PMSTEVEN STEIN
Proposed Sale
3,706$67.94$251.8K

View →

Jul 16, 2025Jul 16 8:07 PMVIJAY IYENGAR
Proposed Sale
983$68.36$67.2K

View →

Jul 16, 2025Jul 16 8:06 PMBARRY FLANNELLY
Proposed Sale
1,340$68.36$91.6K

View →

Jul 16, 2025Jul 16 8:02 PMSHEILA DENTON
Proposed Sale
785$68.36$53.7K

View →

Jul 15, 2025Jul 15 8:41 PMBARRY FLANNELLY
Proposed Sale
1,192$69.86$83.3K

View →

Jul 15, 2025Jul 15 8:37 PMSHEILA DENTON
Proposed Sale
3,330$69.86$232.6K

View →

Jul 15, 2025Jul 15 8:20 PMVIJAY IYENGAR
Proposed Sale
1,177$69.86$82.2K

View →

Jul 14, 2025Jul 14 8:03 PMSTEVEN STEIN
Proposed Sale
14,952$68.47$1.0M

View →

Jul 3, 2025Jul 3 7:10 PMBARRY FLANNELLY
Proposed Sale
10,903$68.15$743.0K

View →

Jul 3, 2025Jul 3 6:46 PMVIJAY IYENGAR
Proposed Sale
8,617$68.15$587.3K

View →

Jul 2, 2025Jul 2 8:27 PMSHEILA DENTON
Proposed Sale
599$68.61$41.1K

View →

Jun 3, 2025Jun 3 8:06 PMSHEILA DENTON
Proposed Sale
1,795$68.00$122.1K

View →

Jun 2, 2025Jun 2 8:26 PMTHOMAS R TRAY
Proposed Sale
651$64.88$42.2K

View →

May 30, 2025May 30 8:03 PMTHOMAS R TRAY
Proposed Sale
963$65.71$63.3K

View →

Mar 14, 2025Mar 14 8:11 PMBARRY FLANNELLY
Proposed Sale
19,807$67.69$1.3M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 8, 2026May 11 8:45 PMBAKER BROS. ADVISORS LPDirector, 10% Owner
Option Exercise
30,000$84.530(I)

View →

May 4, 2026May 6 8:34 PMSuketu UpadhyayEVP & Chief Financial Officer
Grant/Award
51,600$97.1426,342(D)

View →

Apr 17, 2026Apr 21 8:09 PMPablo J CagnoniPresident, Global Head of R&D
Option Exercise
18,667$71.9327,699(D)

View →

Mar 17, 2026Mar 19 8:20 PMPablo J CagnoniPresident, R&D
Option Exercise
18,667$64.2532,910(D)

View →

Feb 19, 2026Feb 23 9:05 PMPablo J CagnoniPresident, R&D
Option Exercise
18,668$61.7616,268(D)

View →

Jan 16, 2026Jan 21 9:06 PMPablo J CagnoniPresident, R&D
Grant/Award
28,475$106.2128,475(D)

View →

Jan 16, 2026Jan 21 9:06 PMSteven H SteinEVP & Chief Medical Officer
Grant/Award
19,932$106.2119,932(D)

View →

Jan 16, 2026Jan 21 9:06 PMMohamed Khairie IssaEVP, Head of US Oncology
Grant/Award
14,237$106.2114,237(D)

View →

Jan 16, 2026Jan 21 9:05 PMMatteo TrottaEVP, GM, Dermatology US
Grant/Award
8,542$106.218,542(D)

View →

Jan 16, 2026Jan 21 9:04 PMThomas TrayPrincipal Accounting Officer
Grant/Award
2,425$106.212,425(D)

View →

Jan 16, 2026Jan 21 9:04 PMPatrick A MayesEVP & Chief Scientific Officer
Grant/Award
4,218$106.214,218(D)

View →